RxDoctor Payments Data

Rachelle Maker

Family · Sterling, CONPI 1609007558

Payments from drug & device makers

$1,205in general payments, 2019–2025

Across 67 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$292
  • Otsuka America Pharmaceutical, Inc.$223
  • Merck$91
  • Exact Sciences$64
  • Biohaven Pharmaceuticals, Inc.$64
  • Sanofi Pasteur Inc.$61
  • plus $409 from 11 others

What the payments were for

  • Food & beverage$1,205100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,205 in reported general payments places this provider in the 80th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$33,797
Medicare patients
108
Services billed
603

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole20$30,395
Synjardy XrEmpagliflozin/Metformin Hcl26$16,759
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$12,250
JardianceEmpagliflozin18$11,792
OzempicSemaglutide12$11,306
XareltoRivaroxaban12$10,744
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,407
GemtesaVibegron12$5,470
Gabapentin128$2,062
Levothyroxine Sodium171$1,254
Atorvastatin Calcium174$1,184
Omeprazole106$1,143
Tamsulosin Hcl46$788
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide53$688
Losartan Potassium70$630

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$223$30,39520 claims
AstraZenecaBreztri Aerosphere$50$12,25015 claims
Novo NordiskOzempic$51$11,30612 claims
Johnson & JohnsonXarelto$21$10,74412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,182 family providers in Colorado.

Other family in Sterling

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →